Cellular pharmacokinetics of telavancin, a novel lipoglycopeptide antibiotic, and analysis of lysosomal changes in cultured eukaryotic cells (J774 mouse macrophages and rat embryonic fibroblasts).
Journal Information
Full Title: J Antimicrob Chemother
Abbreviation: J Antimicrob Chemother
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Anti-Infective Agents
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Funding F. V. B. is Maître de Recherches of the Belgian Fonds National de la Recherche Scientifique. Funding: Belgian Fonds de la Recherche Scientifique (FRS–FNRS) and Belgian Fonds de la Recherche Scientifique Médicale (FRSM; grant nos 1.5.223.05 F, 3.4.549.00 F and 3.4.639.04 F); Belgian Federal Science Policy Office (Research project P5/33; research action P5); Fonds Spéciaux de Recherches and Actions de Recherches Concertées of the Université catholique de Louvain; Grant-in-Aid from Theravance, Inc. (for the pharmacokinetic studies with telavancin)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025